Altimmune Ownership | Who Owns Altimmune?


OverviewForecastRevenueFinancialsChartTranscripts

Altimmune Ownership Summary


Altimmune is owned by 11.02% institutional investors, 0.67% insiders, and 88.31% retail investors. Vanguard group is the largest institutional shareholder, holding 7.82% of ALT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.36% of its assets in Altimmune shares.

ALT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAltimmune11.02%0.67%88.31%
SectorHealthcare Stocks 42.52%10.81%46.67%
IndustryBiotech Stocks 45.18%10.75%44.06%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group6.37M7.82%$24.03M
Blackrock funding, inc. /de6.37M7.82%$24.03M
State street3.60M4.42%$13.58M
Tang capital management2.13M2.62%$8.04M
Geode capital management2.02M2.48%$7.61M
Two sigma investments, lp2.00M2.45%$7.53M
Morgan stanley1.49M1.83%$5.62M
Two sigma advisers, lp1.43M1.75%$5.39M
Millennium management1.11M1.47%$5.56M
Knoll capital management1.12M1.38%$4.23M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Knoll capital management1.12M2.27%$4.23M
Beirne wealth consulting services410.46K0.37%$1.55M
Tang capital management2.13M0.31%$8.04M
Brown wealth management233.67K0.25%$880.95K
Wealth effects59.85K0.07%$225.63K
Summit financial wealth advisors96.29K0.06%$372.63K
Kraematon investment advisors17.43K0.06%$65.73K
Gsa capital partners llp116.77K0.04%$440.00K
Axq capital, lp20.43K0.03%$77.04K
Sherbrooke park advisers15.90K0.03%$59.96K

Top Buyers

HolderShares% AssetsChange
Two sigma investments, lp2.00M0.01%1.56M
Two sigma advisers, lp1.43M0.01%1.30M
Vanguard group6.37M0.00%1.21M
State street3.60M0.00%847.62K
Millennium management1.11M0.00%765.66K

Top Sellers

HolderShares% AssetsChange
Bellevue group---1.06M
Schroder investment management group---961.88K
Federated hermes75.00--915.38K
Caption management130.00K0.00%-850.78K
Capital fund management---726.83K

New Positions

HolderShares% AssetsChangeValue
Point72 asset management476.93K0.00%476.93K$1.80M
Jump financial115.80K0.01%115.80K$436.57K
Janney montgomery scott58.56K0.00%58.56K$221.00K
Bridgeway capital management50.60K0.00%50.60K$190.76K
Engineers gate manager lp41.04K0.00%41.04K$154.73K

Sold Out

HolderChange
Capital performance advisors llp-11.00
Twin peaks wealth advisors-13.00
Tradewinds capital management-20.00
Principal securities-35.00
Quantbot technologies lp-60.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202562-69.46%8,979,026-74.79%110.58%26-77.39%19-50.00%
Jun 30, 20252077.81%37,429,392-1.85%451.80%11540.24%39-29.09%
Mar 31, 20257-96.55%2,264,429-94.40%20.09%2-98.15%2-95.12%
Dec 31, 20241978.84%39,287,627-0.54%551.79%10425.30%41-4.65%
Sep 30, 2024180-4.26%39,499,260-6.80%551.56%83-17.82%43-6.52%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF2.58M3.36%-
Vanguard Total Stock Mkt Idx Inv2.73M3.20%-60.39K
iShares Russell 2000 ETF1.85M2.10%-
SPDR® S&P Biotech ETF1.24M1.41%2.77K
CT (Lux) American Smaller Com 9U USD830.56K1.08%-2.54M
Vanguard Institutional Extnd Mkt Idx Tr882.28K1.04%-406.50K
Fidelity Small Cap Index775.64K0.88%59.16K
Bellevue Healthcare Ord600.00K0.84%600.00K
iShares Russell 2000 Growth ETF673.20K0.76%-
Federated Hermes MDT Small Cap Core IS591.29K0.73%518.67K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 17, 2025Sohn Catherine A.-Buy$5.78K
Mar 13, 2025WEAVER GREGORY L Chief Financial OfficerBuy$52.00K
Aug 19, 2024Drutz David-Sell$56.31K
Aug 19, 2024Drutz David-Sell$54.24K
Aug 15, 2023Drutz David-Buy$862.50

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q3--
2025 Q12-
2024 Q4--
2024 Q3-2

ALT Ownership FAQ


Who Owns Altimmune?

Altimmune shareholders are primarily institutional investors at 11.02%, followed by 0.67% insiders and 88.31% retail investors. The average institutional ownership in Altimmune's industry, Biotech Stocks , is 45.18%, which Altimmune falls below.

Who owns the most shares of Altimmune?

Altimmune’s largest shareholders are Vanguard group (6.37M shares, 7.82%), Blackrock funding, inc. /de (6.37M shares, 7.82%), and State street (3.6M shares, 4.42%). Together, they hold 20.06% of Altimmune’s total shares outstanding.

Does Blackrock own Altimmune?

BlackRock is not among the top 10 institutional shareholders of Altimmune.

Who is Altimmune’s biggest shareholder by percentage of total assets invested?

Knoll capital management is Altimmune’s biggest shareholder by percentage of total assets invested, with 2.27% of its assets in 1.12M Altimmune shares, valued at 4.23M$.

Who is the top mutual fund holder of Altimmune shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Altimmune shares, with 3.36% of its total shares outstanding invested in 2.58M Altimmune shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools